← Back to patent-cliff list
布洛芬
Tier C — Watch / tradeIbuprofen
强生
Originator
1969
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：COXs
Brand：Ibuprox、CDT-<span class="highlightText">ibuprofen</span>、OXPzero <span class="highlightText">ibuprofen</span>、Dorifen、Spedifen、Algifor Junior、Dolgit、Flarin、Amelior、Brufen Retard、Nurofen Meltlets、Motrin、Aktren、Advil、Brufen、Intrafen、司百得、Caldolor、Pedea
Indications (approved)：发热、关节炎、疼痛、动脉导管未闭、咽炎、流感病毒感染、肌肉骨骼痛、背痛
Regional status
US
批准上市
1974-09-19
EU
批准上市
1969-01-01
China
批准上市
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Ibuprofen?
Approved indications include: 发热, 关节炎, 疼痛, 动脉导管未闭, 咽炎, 流感病毒感染, 肌肉骨骼痛, 背痛.
When does the Ibuprofen patent expire?
No public expiry year is available for Ibuprofen yet; this page updates once verified.
How do I get a quote for Ibuprofen intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25